BARCLAYS PLC

Position in ABEO — Abeona Therapeutics Inc.

CIK 312069 LONDON, X0

Position in ABEO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$122,070

-$401,298 QoQ

Shares Held

27,248

-72.6% QoQ

Ownership

0.048%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,145,056 across 362 Biotechnology names. ABEO ranks #239 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	663,263	$296,173,457
2	REGN	Regeneron Pharmaceuticals, Inc.	313,093	$241,908,173
3	ALNY	Alnylam Pharmaceuticals, Inc.	220,623	$72,997,531
4	MRNA	Moderna, Inc.	932,269	$47,359,264
5	INSM	INSMED Inc	275,731	$45,087,531
6	ROIV	Roivant Sciences Ltd.	1,415,848	$39,218,988
7	RVMD	Revolution Medicines, Inc.	383,179	$37,264,156
8	TERN	Terns Pharmaceuticals, Inc.	669,601	$35,301,364

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$122,070	27,248	-72.6%	Shares	Defined	2026-05-15
2025-12-31	$523,368	99,311	+59.4%	Shares	Sole	2026-02-13
2025-09-30	$328,927	62,297	-18.5%	Shares	Sole	2026-03-31
2025-06-30	$433,957	76,401	-9.9%	Shares	Sole	2026-02-27
2025-03-31	$403,481	84,765	+51.1%	Shares	Sole	2026-03-17
2024-12-31	$312,566	56,116	+2.0%	Shares	Sole	2026-03-19
2024-09-30	$347,600	55,000	-28.0%	Shares	Sole	2026-03-31
2024-06-30	$323,910	76,394	+35.5%	Shares	Sole	2026-03-23
2024-03-31	$408,856	56,394	-66.8%	Shares	Sole	2026-03-24
2023-12-31	$850,357	169,732	-54.3%	Shares	Sole	2026-03-24
2023-09-30	$1,563,071	371,276	+100.0%	Shares	Sole	2026-03-26
2023-06-30	$748,121	185,638	0.0%	Shares	Sole	2026-03-27
2023-03-31	$523,499	185,638	0.0%	Shares	Sole	2026-03-30
2022-12-31	$571,765	185,638	+4972.1%	Shares	Sole	2026-03-30
2022-09-30	$11,126	3,660	—	Shares	Sole	2022-11-03
No filing history on record for this holder in this stock.